PTCHD4, a transmembrane protein with no previously defined role in aging, accumulates with age and stress and actively drives cellular senescence via AKT activation. Mice lacking PTCHD4 showed reduced senescence markers and inflammatory signaling, preserved lung function after fibrotic injury, and extended median lifespan in a chemically accelerated aging model. The PTCHD4–AKT axis is proposed as a candidate target in senescence-associated disease.
Key Points
- PTCHD4 rises with age across mouse tissues and human lung data
- Loss of PTCHD4 extended median lifespan in accelerated-aging mice
- PTCHD4 deficiency reduced lung collagen deposition and preserved pulmonary function
Longevity Analysis
Senescent cells accumulate not only through internal damage but through surface-level signaling that tells a cell to stop dividing and start broadcasting inflammatory messages to its neighbors. Locating that decision at the cell membrane, in a protein that responds to injury and age-related stress, offers a point of intervention upstream of the inflammatory cascade that degrades lung tissue, slows repair, and burdens immune surveillance. Reversal of the protective effect by restoring AKT signaling identifies the specific mechanism, which matters for anyone evaluating how senolytic and senomorphic strategies might eventually be targeted rather than applied broadly.
Original published by Wiley Aging Cell, by Mingyue Wang, Zhaoyun Yang, Qikai Wang, Zeping Li, Zhihua Huang, Le Wang, Xiaoning Sun, Donglin Yu, Wenhua Yu, Xiaoxia Bao, Zebin Mao, Yang Li .